TMED Holdings — T. Rowe Price Health Care ETF
All 106 reported holdings of T. Rowe Price Health Care ETF (TMED) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 14.48% | $2.93M |
| Unitedhealth Group, Inc. | 6.54% | $1.33M |
| Thermo Fisher Scientific, Inc. | 4.59% | $930.47K |
| Gilead Sciences, Inc. | 4.14% | $839.01K |
| Abbott Laboratories | 3.91% | $792.61K |
| Danaher Corp. | 2.73% | $553.25K |
| Medtronic PLC | 2.24% | $454.48K |
| Alnylam Pharmaceuticals, Inc. | 2.06% | $417.56K |
| Stryker Corp. | 2.00% | $405.81K |
| Dyne Therapeutics, Inc. | 1.88% | $380.17K |
| Waters Corp. | 1.75% | $354.98K |
| Becton Dickinson And Co. | 1.71% | $346.22K |
| Agilent Technologies, Inc. | 1.69% | $341.48K |
| Elanco Animal Health, Inc. | 1.59% | $321.33K |
| Humana, Inc. | 1.57% | $318.17K |
| Cytokinetics, Inc. | 1.54% | $311.23K |
| West Pharmaceutical Services | 1.48% | $300.27K |
| Boston Scientific Corp. | 1.47% | $297.75K |
| Ascendis Pharma A/s - ADR | 1.39% | $282.48K |
| Biogen, Inc. | 1.26% | $254.83K |
| Vaxcyte, Inc. | 1.19% | $240.34K |
| Immunome, Inc. | 1.15% | $233.33K |
| Mettler-Toledo International | 1.11% | $224.49K |
| Cencora, Inc. | 1.06% | $215.19K |
| Apellis Pharmaceuticals, Inc. | 1.02% | $207.67K |
| Regeneron Pharmaceuticals | 1.02% | $206.29K |
| Dexcom, Inc. | 1.01% | $204.16K |
| Cvs Health Corp. | 0.96% | $193.77K |
| Moonlake Immunotherapeutics | 0.89% | $181.16K |
| Insulet Corp. | 0.83% | $168.50K |
| Adaptive Biotechnologies | 0.83% | $167.73K |
| Bicara Therapeutics, Inc. | 0.82% | $165.29K |
| Biontech SE-ADR | 0.80% | $162.56K |
| Immatics NV | 0.80% | $161.06K |
| Repligen Corp. | 0.79% | $160.12K |
| Cooper Cos Inc/the | 0.78% | $157.09K |
| Shattuck Labs, Inc. | 0.77% | $155.03K |
| Idexx Laboratories, Inc. | 0.74% | $149.46K |
| Xenon Pharmaceuticals, Inc. | 0.73% | $148.75K |
| Sarepta Therapeutics, Inc. | 0.73% | $148.34K |
| Bristol-Myers Squibb Co. | 0.73% | $147.50K |
| Molina Healthcare, Inc. | 0.71% | $144.23K |
| Apogee Therapeutics, Inc. | 0.69% | $139.55K |
| Cg Oncology, Inc. | 0.68% | $137.26K |
| Agios Pharmaceuticals, Inc. | 0.65% | $132.14K |
| Incyte Corp. | 0.65% | $131.58K |
| Kymera Therapeutics, Inc. | 0.62% | $124.69K |
| Novo-Nordisk A/s-Spons ADR | 0.58% | $117.60K |
| Cabaletta Bio, Inc. | 0.58% | $117.36K |
| Align Technology, Inc. | 0.54% | $108.69K |
| Alkermes PLC | 0.53% | $107.78K |
| Rapport Therapeutics, Inc. | 0.52% | $106.14K |
| Maplight Therapeutics, Inc. | 0.51% | $103.89K |
| Avalo Therapeutics, Inc. | 0.51% | $103.23K |
| Kodiak Sciences, Inc. | 0.51% | $103.11K |
| Erasca, Inc. | 0.51% | $102.71K |
| Natera, Inc. | 0.50% | $100.79K |
| Denali Therapeutics, Inc. | 0.48% | $98.23K |
| Novocure Ltd. | 0.46% | $93.72K |
| Grs - Security Lending Collateral | 0.46% | $93.61K |
| Stevanato Group Spa | 0.44% | $89.50K |
| Guardant Health, Inc. | 0.42% | $85.81K |
| Arcus Biosciences, Inc. | 0.41% | $82.79K |
| Stoke Therapeutics, Inc. | 0.40% | $80.36K |
| Amylyx Pharmaceuticals, Inc. | 0.39% | $79.38K |
| Centessa Pharmaceuticals-ADR | 0.39% | $79.04K |
| Edwards Lifesciences Corp. | 0.38% | $77.76K |
| Immunocore Holdings PLC-ADR | 0.37% | $74.41K |
| Grail, Inc. | 0.36% | $72.56K |
| Dianthus Therapeutics, Inc. | 0.35% | $71.16K |
| Icon PLC | 0.33% | $67.72K |
| Prime Medicine, Inc. | 0.32% | $64.21K |
| Crinetics Pharmaceuticals In | 0.32% | $63.85K |
| Ionis Pharmaceuticals, Inc. | 0.32% | $63.83K |
| Eikon Therapeutics, Inc. | 0.30% | $61.79K |
| Intuitive Surgical, Inc. | 0.30% | $61.77K |
| Caris Life Sciences, Inc. | 0.30% | $60.38K |
| Travere Therapeutics, Inc. | 0.29% | $58.89K |
| Genedx Holdings Corp. | 0.28% | $57.22K |
| Disc Medicine, Inc. | 0.27% | $53.77K |
| Relay Therapeutics, Inc. | 0.26% | $51.79K |
| Annexon, Inc. | 0.25% | $51.61K |
| Ypsomed Holding AG-Reg | 0.25% | $49.78K |
| Aktis Oncology, Inc. | 0.24% | $48.68K |
| Oscar Health, Inc. - Class A | 0.23% | $45.87K |
| Enliven Therapeutics, Inc. | 0.22% | $44.49K |
| Charles River Laboratories | 0.21% | $43.47K |
| Bruker Corp. | 0.21% | $43.20K |
| Biohaven Ltd. | 0.19% | $39.11K |
| Procept Biorobotics Corp. | 0.18% | $36.26K |
| Crispr Therapeutics AG | 0.17% | $33.73K |
| Black Diamond Therapeutics I | 0.16% | $33.11K |
| Bio-Techne Corp. | 0.15% | $30.99K |
| Olema Pharmaceuticals, Inc. | 0.15% | $29.78K |
| State Street Ins US Go Mm Fd-Is | 0.13% | $27.01K |
| Soleno Therapeutics, Inc. | 0.13% | $26.11K |
| Personalis, Inc. | 0.13% | $25.35K |
| Karyopharm Therapeutics, Inc. | 0.12% | $24.98K |
| Janux Therapeutics, Inc. | 0.10% | $20.22K |
| Tango Therapeutics, Inc. | 0.10% | $19.52K |
| Schrodinger, Inc. | 0.09% | $18.88K |
| Immunovant, Inc. | 0.09% | $18.58K |
| Billiontoone, Inc. Cl A | 0.09% | $18.00K |
| Revolution Medicines, Inc. | 0.05% | $9.24K |
| Metsera, Inc. Cvr | 0.00% | $0 |
| Applied Therapeutics, Inc. Cvr | 0.00% | $0 |
TMED overview: performance, fees, allocation and SEC filings